Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;21(10):1339-1341.
doi: 10.1016/S1473-3099(20)30851-3. Epub 2021 Jun 16.

Moving forward with an imperfect vaccine

Lorenzo Pezzoli  1 , Andrew S Azman  2
Affiliations

Moving forward with an imperfect vaccine

Lorenzo Pezzoli et al. Lancet Infect Dis. 2021 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

ASA declares funding related to oral cholera vaccines from the Bill and Melinda Gates Foundation. LP declares no competing interests.

References

    1. Greenwood B, Dicko A, Sagara I. Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine. Malar J. 2017;16:182. - PMC - PubMed
    1. Iboi EA, Ngonghala CN, Gumel AB. Will an imperfect vaccine curtail the COVID-19 pandemic in the U.S.? Infect Dis Model. 2020;5:510–524. - PMC - PubMed
    1. Pezzoli L. Global oral cholera vaccine use, 2013–2018. Vaccine. 2020;38(suppl 1):A132–A140. - PMC - PubMed
    1. Bi Q, Ferreras E, Pezzoli L. Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17:1080–1088. - PMC - PubMed
    1. Franke MF, Ternier R, Jerome JG, Matias WR, Harris JB, Ivers LC. Long-term effectiveness of one and two doses of a killed, bivalent, whole-cell oral cholera vaccine in Haiti: an extended case-control study. Lancet Glob Health. 2018;6:e1028–e1035. - PMC - PubMed

Publication types

Substances